|
Issue Open Date
|
09-Oct-25
|
|
Issue Closing Date
|
13-Oct-25
|
|
Application Money
|
100
|
|
Allotment Money
|
|
|
|
|
Price Band
|
461
-
485
|
|
Minimium Application No.
|
30
|
|
Issue Size (Shares)
|
16455670
|
|
Market Lot
|
1
|
|
|
|
Objective
|
1. Prepayment or scheduled repayment of all or a portion of certain outstanding borrowings availed by our Company2. Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposes
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
Offered / Reserved |
Bid For |
|
Non-Institutional Investors
|
4476409
|
8161230
|
1.82316450529878
|
Qualified Institutional Buyers
|
8952820
|
18917340
|
2.113003500573
|
Retail Individual Investors
|
2984273
|
11757660
|
3.93987413349918
|
|
|
|
Business Description
We are a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of specialty products and drug-device combination products targeting regulated markets and in particular the United States. Based on the peer set (of six listed Indian companies assessed by F&S, and our Company), we are the only Indian pharmaceutical player with a complete focus on regulated markets.
|
|
Promoter's Holding
|
|
Total Share Capital
|
120407506
|
|
Offered to Public
|
29884901
|
|
Promoter's Holding (Pre-Issue)
|
77.97
|
|
Promoter's Holding (Post-Issue)
|
|
|
|
|
|
|
|
|
Address |
Medone House B-75 Road No. 33 Wagle Estate Thane (West)
Thane,
Maharashtra,
400604
Phone : 022- 61414000
Email : secretarial@rubicon.co.in
Website : www.rubicon.co.in
|
|
Registrar |
MUFG Intime India Pvt Ltd.
C 101 247 Park LBS Marg Vikhroli (West) Mumbai
|
|
Listed at |
BSE, NSE
|
|
Lead Manager |
Axis Capital Ltd. IIFL Securities Ltd. JM Financial Ltd. SBI Capital Markets Ltd
|
|
Promoters |
General Atlantic Singapore RR Pte. Ltd. Parag Suganchand Sancheti Pratibha Pilgaonkar Sudhir Dhirendra Pilgaonkar Sumant Sudhir Pilgaonkar Surabhi Parag Sancheti
|
|